Literature DB >> 24574412

Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.

Brian S Wakeman1, L Steven Johnson, Clinton R Paden, Kathleen S Gray, Herbert W Virgin, Samuel H Speck.   

Abstract

UNLABELLED: The essential immediate early transcriptional activator RTA, encoded by gene 50, is conserved among all characterized gammaherpesviruses. Analyses of a recombinant murine gammaherpesvirus 68 (MHV68) lacking both of the known gene 50 promoters (G50DblKo) revealed that this mutant retained the ability to replicate in the simian kidney epithelial cell line Vero but not in permissive murine fibroblasts following low-multiplicity infection. However, G50DblKo replication in permissive fibroblasts was partially rescued by high-multiplicity infection. In addition, replication of the G50DblKo virus was rescued by growth on mouse embryonic fibroblasts (MEFs) isolated from IFN-α/βR-/- mice, while growth on Vero cells was suppressed by the addition of alpha interferon (IFN-α). 5' rapid amplification of cDNA ends (RACE) analyses of RNAs prepared from G50DblKo and wild-type MHV68-infected murine macrophages identified three novel gene 50 transcripts initiating from 2 transcription initiation sites located upstream of the currently defined proximal and distal gene 50 promoters. In transient promoter assays, neither of the newly identified gene 50 promoters exhibited sensitivity to IFN-α treatment. Furthermore, in a single-step growth analysis RTA levels were higher at early times postinfection with the G50DblKo mutant than with wild-type virus but ultimately fell below the levels of RTA expressed by wild-type virus at later times in infection. Infection of mice with the MHV68 G50DblKo virus demonstrated that this mutant virus was able to establish latency in the spleen and peritoneal exudate cells (PECs) of C57BL/6 mice with about 1/10 the efficiency of wild-type virus or marker rescue virus. However, despite the ability to establish latency, the G50DblKo virus mutant was severely impaired in its ability to reactivate from either latently infected splenocytes or PECs. Consistent with the ability to rescue replication of the G50DblKo mutant by growth on type I interferon receptor null MEFs, infection of IFN-α/βR-/- mice with the G50DblKo mutant virus demonstrated partial rescue of (i) acute virus replication in the lungs, (ii) establishment of latency, and (iii) reactivation from latency. The identification of additional gene 50/RTA transcripts highlights the complex mechanisms involved in controlling expression of RTA, likely reflecting time-dependent and/or cell-specific roles of different gene 50 promoters in controlling virus replication. Furthermore, the newly identified gene 50 transcripts may also act as negative regulators that modulate RTA expression. IMPORTANCE: The viral transcription factor RTA, encoded by open reading frame 50 (Orf50), is well conserved among all known gammaherpesviruses and is essential for both virus replication and reactivation from latently infected cells. Previous studies have shown that regulation of gene 50 transcription is complex. The studies reported here describe the presence of additional alternatively initiated, spliced transcripts that encode RTA. Understanding how expression of this essential viral gene product is regulated may identify new strategies for interfering with infection in the setting of gammaherpesvirus-induced diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574412      PMCID: PMC4019092          DOI: 10.1128/JVI.03110-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases.

Authors:  A Whitehouse; I M Carr; J C Griffiths; D M Meredith
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Authors:  Jung D Kim; Chang H Kim; Byoung S Kwon
Journal:  Mol Cells       Date:  2011-01-11       Impact factor: 5.034

4.  Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

5.  Essential role of Rta in lytic DNA replication of Epstein-Barr virus.

Authors:  Ayman El-Guindy; Maryam Ghiassi-Nejad; Sean Golden; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein.

Authors:  Xiaozhen Liang; Young C Shin; Robert E Means; Jae U Jung
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Identification of an Rta responsive promoter involved in driving gammaHV68 v-cyclin expression during virus replication.

Authors:  Robert D Allen; Mark N DeZalia; Samuel H Speck
Journal:  Virology       Date:  2007-05-02       Impact factor: 3.616

8.  KSHV- and EBV-associated germinotropic lymphoproliferative disorder: a rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy.

Authors:  Antonio D'Antonio; D'Antonio Antonio; Amedeo Boscaino; Boscaino Amedeo; Maria Addesso; Addesso Maria; Miguel Angel Piris; Piris Miguel Angel; Oscar Nappi; Nappi Oscar
Journal:  Leuk Lymphoma       Date:  2007-07

9.  Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50.

Authors:  Megan M Goodwin; Susan Canny; Ashley Steed; Herbert W Virgin
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Simple and highly efficient BAC recombineering using galK selection.

Authors:  Søren Warming; Nina Costantino; Donald L Court; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

View more
  6 in total

1.  Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.

Authors:  Brian S Wakeman; Yoshihiro Izumiya; Samuel H Speck
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

2.  Th2 Cytokine Modulates Herpesvirus Reactivation in a Cell Type Specific Manner.

Authors:  Guoxun Wang; Christina Zarek; Tyron Chang; Lili Tao; Alexandria Lowe; Tiffany A Reese
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

3.  Multiple Transcripts Encode Full-Length Human Cytomegalovirus IE1 and IE2 Proteins during Lytic Infection.

Authors:  Kyle C Arend; Benjamin Ziehr; Heather A Vincent; Nathaniel J Moorman
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter.

Authors:  T A Reese; B S Wakeman; H S Choi; M M Hufford; S C Huang; X Zhang; M D Buck; A Jezewski; A Kambal; C Y Liu; G Goel; P J Murray; R J Xavier; M H Kaplan; R Renne; S H Speck; M N Artyomov; E J Pearce; H W Virgin
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

5.  Genome-wide Transcript Structure Resolution Reveals Abundant Alternate Isoform Usage from Murine Gammaherpesvirus 68.

Authors:  Tina O'Grady; April Feswick; Brett A Hoffman; Yiping Wang; Eva M Medina; Mehmet Kara; Linda F van Dyk; Erik K Flemington; Scott A Tibbetts
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

6.  The murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cells.

Authors:  Brigid M O'Flaherty; Tanushree Soni; Brian S Wakeman; Samuel H Speck
Journal:  PLoS Pathog       Date:  2014-08-07       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.